Pediatric Epilepsy
Researchers have shown therapeutic efficacy of a new experimental drug in mouse models of Alzheimer's disease and a rare genetic form of epilepsy known as Dravet syndrome.
Pediatric Epilepsy
A clinical trial is evaluating the safety and tolerability of a nutritional formulation containing the ketone beta-hydroxybutyrate (BHB) as a treatment to help control seizures in children with Angelman syndrome.
Researchers at Lund University in Sweden have used a neuropeptide to successfully reduce seizure-like activity in tissue from patients with drug-resistant epilepsy.
CBD
Changes in norclobazam and clobazam levels do not have a clinically significant correlation with changes in weekly seizure frequency for those taking cannabidiol with clobazam.
Researchers state that their robotic paradigm can detect impairments in various sensorimotor and cognitive functions across the population with epilepsy.
VALTOCO is the first nasal spray approved by the FDA as a rescue treatment for people with epilepsy aged 6 and older
Genetics
The program will be expanded to make no-charge testing available for healthcare providers to order for any child under the age of eight who has an unprovoked seizure.
Learn about some of our exciting 2020 programming.
